Our findings revealed a novel miR-200a-3p-YAP signaling axis in HPV-negative C33A cells, and this signaling axis may have potential values in the treatment and prognosis specifically for HPV-negative patients with cervical cancer. Here, YAP1 is linked to cervical carcinoma.